Mesoblast Limited (ASX:MSB) Announce Research Note By ABN AMRO Equities Australia
Mesoblast Limited (ASX:MSB)(US:MBLTY) Announce Research Note By ABN AMRO
Companies in the News
Biotech
Benitec Limited (ASX:BLT) Secures Further Rights to HIV Therapeutic Collaboration with City of Hope in HIV Trial
Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX: BLT)(PINK: BNIKF) has secured further intellectual property rights that underpin its HIV/AIDS lymphoma therapeutic currently under going clinical trials at City of Hope in Duarte, California. The therapeutic uses RNAi technology covered by Benitec's patent portfolio.
Starpharma Holdings (ASX:SPL) Advise Opes Prime Overhang Cleared
Starpharma Holdings Ltd (ASX:SPL)(OTCQX:SPHRY) has been advised that all of the Company's shares held by ANZ pursuant to stock lending arrangements associated with the Opes Prime Group have now been sold in an orderly fashion.
Benitec Limited (ASX:BLT) Wins In US Supreme Court
The Directors of Benitec Limited (ASX: BLT) announced today that the US Supreme Court met on Friday to decide on Benitec's Motion of Respondent for Leave to File a Brief in Opposition Under Seal. Today Benitec was not only notified that the motion was granted. The Court also stated that "The petition for a writ of certiorari is denied."
Solagran Limited (ASX:SLA) Update on Ropren Production and Marketing In Russia
The Directors of Solagran Limited (ASX: SLA; PNK: SOGRF) are pleased to provide an update in relation to the production and marketing of Ropren(R) in Russia.
Starpharma Holdings (ASX:SPL) Announce Commercial Product Launch Of Priostar(R) Dendrimer Technology As NanoJuiceTM
Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced the first commercial product launch based on its Priostar(R) dendrimer technology. The product, a research reagent kit called NanoJuiceTM Transfection Kit for transporting DNA into cells, was developed under a license and supply agreement established in February 2007 between Starpharma's wholly owned US subsidiary Dendritic Nanotechnologies (DNT) and EMD Chemicals Inc., an affiliate of Merck KGaA, Darmstadt, Germany.
Starpharma Holdings (ASX:SPL) Excellence In Biotechnology Investment 2008 Conference - CEO Investor Presentation
Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) advises that CEO Dr Jackie Fairley is today presenting at the Excellence in Biotechnology Investment 2008 conference in Sydney.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) LF-07 Intersects 54 Metres of net Coal
- Central Petroleum Limited (ASX:CTP) Live Online Investor Presentation
- State Gas Limited (ASX:GAS) Quarterly Activities Report
- Beetaloo Energy Australia Limited (ASX:BTL) Quarterly Activities Report - 30 June
- Basin Energy Ltd (ASX:BSN) Quarterly Activities Report
- Central Petroleum Limited (ASX:CTP) Share Buy-Back
Life Sciences
- Ellis Martin Report: Redefining Cancer Treatment - RenovoRx, Inc. (NASDAQ:RNXT) CEO Shaun Bagai on Targeted Pancreatic Therapy
- BPH Energy Limited (ASX:BPH) Quarterly Activities Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Quarterly Activities/Appendix 4C Cash Flow Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-Gen PromarkerD Test Performance Results Published
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
Social Media
